A carregar...
Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)
PURPOSE: Cariprazine is a potent dopamine D(3)-preferring D(3)/D(2) receptor partial agonist in development for the treatment of schizophrenia, bipolar mania, and depression. Pharmacokinetics of cariprazine and the two clinically relevant metabolites (desmethyl- and didesmethyl-cariprazine) was eval...
Na minha lista:
| Publicado no: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4716719/ https://ncbi.nlm.nih.gov/pubmed/26834462 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S95100 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|